---
title: "Eli Lilly will launch late-stage trials for its amylin-based weight loss drug"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/264676832.md"
description: "Eli Lilly stated that after its experimental insulin weight-loss drug showed positive results in mid-term studies, it will begin late-stage trials next month. The company indicated that the highest weekly dose of Irlaglutide can help obese or overweight patients lose an average of 20.1% of their weight over 48 weeks"
datetime: "2025-11-06T13:49:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264676832.md)
  - [en](https://longbridge.com/en/news/264676832.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264676832.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/264676832.md) | [English](https://longbridge.com/en/news/264676832.md)


# Eli Lilly will launch late-stage trials for its amylin-based weight loss drug

Eli Lilly (LLY.US) stated that after its experimental glucagon-like peptide-1 weight loss drug showed positive results in mid-stage studies, it will begin late-stage trials next month.

The company indicated that weekly injections of the maximum dose of eloralin can help obese or overweight patients lose an average of 20.1% of their weight over 48 weeks

### 相關股票

- [Eli Lilly (LLY.US)](https://longbridge.com/zh-HK/quote/LLY.US.md)

## 相關資訊與研究

- [Eli Lilly pushes for NHS drug price increases in return for its UK investment, FT reports](https://longbridge.com/zh-HK/news/280952509.md)
- [<![CDATA[Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments]]>](https://longbridge.com/zh-HK/news/281203519.md)
- [NEUBERGER ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES INCREASE IN DISTRIBUTION RATE AND DECLARATION OF NEXT MONTHLY DISTRIBUTION | NML Stock News](https://longbridge.com/zh-HK/news/280684404.md)
- [Lilly To Acquire Centessa; Upfront Consideration Represents Equity Value Of Approx. $6.3 Bln](https://longbridge.com/zh-HK/news/281174134.md)
- [Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | LLY Stock News](https://longbridge.com/zh-HK/news/281171668.md)